DiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Treatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsDrug Administration ScheduleSurvival AnalysisDisease-Free SurvivalCombined Modality TherapyProspective StudiesCisplatinPatient SelectionVincristineSurvival RateDoxorubicinFollow-Up StudiesInfusions, IntravenousNeoplasm StagingTime FactorsRetrospective StudiesCyclophosphamideFeasibility StudiesEtoposideNeoplasm Recurrence, LocalPaclitaxelAntineoplastic AgentsFluorouracilVinblastineIfosfamideChemotherapy, AdjuvantRemission InductionQuality of LifeDeoxycytidineLung NeoplasmsKaplan-Meier EstimateCarboplatinPrognosisPrednisoneDacarbazineGuideline AdherenceNeutropeniaDouble-Blind MethodRecurrenceMaximum Tolerated DoseResearch DesignPatient ComplianceEligibility DeterminationQuestionnairesMethotrexateDisease ProgressionBleomycinAdenocarcinomaClinical ProtocolsRisk FactorsAntimetabolites, AntineoplasticCarcinoma, Non-Small-Cell LungDose-Response Relationship, DrugMulticenter Studies as TopicBreast NeoplasmsOrganoplatinum CompoundsSalvage TherapyTaxoidsRadiotherapy, AdjuvantAdministration, OralAntibodies, Monoclonal, HumanizedPilot ProjectsAntineoplastic Agents, PhytogenicProcarbazineUnited StatesPractice Guidelines as TopicPeritoneal NeoplasmsPatient SatisfactionCohort StudiesIntention to Treat AnalysisPrimary Health CareVindesineRadiotherapyMultivariate AnalysisTreatment FailureNeoadjuvant TherapyClinical Trials, Phase IV as TopicEmergency Service, HospitalCamptothecinColorectal NeoplasmsLeucovorinRisk AssessmentQuality Indicators, Health CareDrug Therapy, CombinationRadiotherapy DosageOutcome Assessment (Health Care)Brain Stem NeoplasmsReminder SystemsAntineoplastic Agents, AlkylatingNeoplasm MetastasisLomustineThrombocytopeniaFallopian Tube NeoplasmsProportional Hazards ModelsChemoradiotherapyEpirubicinCarcinoma, Small CellThrombolytic TherapyPhysician's Practice Patterns